
Auteur M. PASINETTI
|
Documents disponibles écrits par cet auteur (4)

Identifying the co-occurrence of drug use and mental health disorders in the same individuals is essential for effective treatment of their drug use problems. Reviewing the available information on psychiatric co-morbidity among drug users in Eu[...]
P. DELUCA ; Z. DAVEY ; O. CORAZZA ; L. DI FURIA ; M. FARRE ; L. H. FLESLAND ; M. MANNONEN ; A. MAJAVA ; T. PELTONIEMI ; M. PASINETTI ; C. PEZZOLESI ; N. SCHERBAUM ; H. SIEMANN ; A. SKUTLE ; M. TORRENS ; P. VAN DER KREEFT ; E. IVERSEN ; F. SCHIFANO | 2012
Dans Progress in Neuro-Psychopharmacology and Biological Psychiatry (Vol.39, n°2, 3 December 2012) Article : PériodiqueBACKGROUND: This paper presents the outcomes of the 2-year European Union funded Psychonaut Web Mapping Project which aimed at developing and implementing an integrated web mapping system to promptly identify and learn about novel psychoactive s[...]
O. CORAZZA ; F. SCHIFANO ; P. SIMONATO ; S. FERGUS ; S. ASSI ; J. L. STAIR ; J. CORKERY ; G. TRINCAS ; P. DELUCA ; Z. DAVEY ; U. BLASZKO ; Z. DEMETROVICS ; J. MOSKALEWICZ ; A. ENEA ; G. DI MELCHIORRE ; B. MERVO ; L. DI FURIA ; M. FARRE ; L. H. FLESLAND ; M. PASINETTI ; C. PEZZOLESI ; A. PISARSKA ; H. SHAPIRO ; H. SIEMANN ; A. SKUTLE ; E. SFERRAZZA ; M. TORRENS ; P. VAN DER KREEFT ; D. ZUMMO ; N. SCHERBAUM | 2012
Dans Human Psychopharmacology: Clinical and Experimental (Vol.27, n°2, March 2012) Article : PériodiqueOn the basis of the material available both in the scientific literature and on the web, this paper aims to provide a pharmacological, chemical and behavioural overview of the novel compound methoxetamine. This is a dissociative drug related to [...]
L. MONTANARI ; M. PASINETTI ; B. GUARITA ; L. ROYUELA ; K. MULLIGAN ; J. VICENTE ; D. KLEMPOVA ; A. PIRONA ; A. GYARMATHY | 2013
Dans Drugs: Education, Prevention and Policy (Vol.20, n°1, February 2013) Article : PériodiqueThe aim of this article is to explore the prevalence of primary illicit stimulant use among people who enter drug treatment in Europe. Drawing on information provided by European Union treatment centres in 2009 (excluding Latvia, Lithuania, Port[...]